$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺什么时间段服用最好?
2025-10-19 11:44:20
Check Details
阿比特龙能够吃多久?
2025-10-19 11:44:20
Check Details
恩杂鲁胺中国上市的日期
2025-10-19 11:44:20
Check Details
阿比特龙耐药了应该怎么解决?
2025-10-19 11:44:20
Check Details
恩杂鲁胺价格多少?
2025-10-19 11:44:20
Check Details
泽珂中文说明书
2025-10-19 11:44:20
Check Details
恩杂鲁胺什么时间上市的?
2025-10-19 11:44:20
Check Details
2019年最新版泽珂完整说明书
2025-10-19 11:44:20
Check Details
恩杂鲁胺跟阿比特龙的区别
2025-10-19 11:44:20
Check Details
阿比特龙在中国是什么价格?
2025-10-19 11:44:20
Check Details
恩杂鲁胺与其他靶向药相比较有什么优势?
2025-10-19 11:44:20
Check Details
泽珂治什么?
2025-10-19 11:44:20
Check Details
1
2
...
1316
1317
1318
1319
1320
1321
1322
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
3
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
4
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
5
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
6
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
7
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
8
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
9
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
10
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
11
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
12
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring